USANA Health Sciences Reports Net Sales of $233.3 Million; 31% Increase in EPS for Third Quarter 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/16/2026
- Wall Street gyrates after Fed hikes interest rate to battle inflation
- Oil slips as Saudi Arabia offers more crude via Oman
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- U.S. Commerce Department to sell up to 9.9M GlobalFoundries shares
- AI chip sell-off overblown: Zero GPU slowdown after Anthropic essay, analyst says
- Wall Street ends lower as oil spikes and the benchmark Treasury yield breaches 5%
- Wall Street gyrates after Fed hikes interest rate to battle inflation
- Stocks tend to rise after the Fed starts to hike
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
USANA Health Sciences (USNA) Tops Q3 EPS by 16c; Boosts FY15 EPS Outlook
November 3, 2015 4:18 PM ESTUSANA Health Sciences (NYSE: USNA) reported Q3 EPS of $1.92, $0.16 better than the analyst estimate of $1.76. Revenue for the quarter came in at $233.3 million versus the consensus estimate of $224.53 million.
USANA Health Sciences sees FY2015 EPS of $7.25-$7.35, versus prior guidance of $6.90-$7.20 and... More
